α/β-T cell receptor-directed therapy in rat cardiac allograft recipients: Treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejection

Transplantation

Volumn 59, Issue 1, 1995, Pages 78-84

  Heidecke, Claus Dieter ^a   Hancock, Wayne W ^b   Jakobs, Frank ^a   Zantl, Niko ^a   Kurrle, Roland ^c   Westerholt, Sören ^a   Sewczik, Thomas ^a   Deusch, Kai ^a   Kupiec Weglinski, Jerzy ^d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^c Behringwerke AG   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX19; MONOCLONAL ANTIBODY OX8; MONOCLONAL ANTIBODY R73; MONOCLONAL ANTIBODY W3 25; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTERFERON PRODUCTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMAL; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIUM; RATS; RATS, INBRED BN; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HOMOLOGOUS;

EID: 0028981462     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199501150-00014     Document Type: Article

References (49)

1. Kupiec-Weglinski JW, Diamantstein T, Tilney NL. Interleukin 2 receptor-targeted therapy-rationale and applications in organ transplantation. Transplantation 1988; 46: 785.
2. Wood KJ, Pearson TC, Darby C, Morris PJ. CD4: a potential target molecule for immunosuppressive therapy and tolerance induction. Transplant Rev 1991; 5: 150.
3. Kupiec-Weglinski JW, Heidecke CD, Araujo JL, et al. Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat. Cell Immunol 1985; 93: 168.
4. Kupiec-Weglinski JW, Tilney NL, Stunkel KG, et al. Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts. Transplantation 1989; 47: 11.
5. Sayegh MH, Kut JP, Milford EL. Anti-CD4 monoclonal antibody effects cellular hyporesponsiveness and prolongs renal al lograft survival in the rat. Hum Immunol 1989; 26: 131.
6. Sayegh MH, Sablinski T, Tanaka K, et al. Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. Transplantation 1991; 51: 296.
7. Shizuru JA, Seydel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 1990; 50: 366.
8. Sablinski T, Sayegh MH, Hancock WW, et al. Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection. Transplantation 1991; 51: 226.
9. Sablinski T, Sayegh MH, Kut JP, Tilney NL, Milford EL, Kupiec-Weglinski JW. The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival. Transplantation 1992; 53: 219.
10. Kupiec-Weglinski JW, Sablinski T, Hancock WW, et al. Modu lation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy. Transplantation 1991; 51: 300.
11. Sablinski T, Hancock WW, Tilney NL, Kupiec-Weglinski JW. Biology of vascularized organ allograft rejection in sensitized recipients. Transplant Rev 1990; 4: 108.
12. Hancock WW, DiStefano R, Braun P, Schweizer RT, Tilney NL, Kupiec-Weglinski JW. Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms. Transplantation 1990; 49: 416.
13. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
14. Krensky AM, Weiss A, Crabtree G, Davis MM, Parham P. T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med 1990; 322: 510.
15. Meuer SC, Acuto O, Hussey RE, et al. Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor. Nature 1983; 303: 808.
16. Yague J, White J, Coleclough C, Kappler J, Palmer E, Marrack P. The T cell receptor: the alpha and beta chains define idio-type, and antigen and MHC specificity. Cell 1985; 42: 81.
17. Hünig T, Wallny HJ, Hartley JK, Lawetzky A, Tiefenthaler G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J Exp Med 1989; 169: 73.
18. Lawetzky A, Tiefenthaler G, Kubo R, Hünig T. Identification and characterization of rat T cell subpopulations expressing T cell receptors alpha/beta and gamma/delta. Eur J Immunol 1990; 20: 343.
19. Yoshino S, Schlipköter E, Kinne R, Hünig T, Emmrich F. Sup pression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the alpha/beta T cell receptor. Eur J Immunol 1990; 20: 2805.
20. Yoshino S, Cleland LG. Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats. J Exp Med 1992; 175: 907.
21. Yoshino S, Cleland LG, Mayrhofer G, Brown RR, Schwab JH. Prevention of chronic erosive streptococcal cell wall-induced arthritis in rats by treatment with a monoclonal antibody against the T cell antigen receptor alpha beta. J Immunol 1991; 146: 4187.
22. Jung S, Kramer S, Schluesener HJ, Hünig T, Toyka K, Hartung HP. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta. J Immunol 1992; 148: 3768.
23. Tsuchida M, Hirahara H, Matsumoto Y, Abo T, Eguchi S. Induc tion of specific unresponsiveness to cardiac allografts by short term administration of anti-T cell receptor alpha/beta antibody. Transplantation 1994; 57: 256.
24. van den Bogaerde J, White D, Roser B, Kampinga J, Aspinall R. In vitro and in vivo effects of monoclonal antibodies against T cell subsets on allogeneic and xenogeneic responses in the rat. Transplantation 1990; 50: 915.
25. Hancock WW, Alberghini TV, Chen WM. Production and use of neutralizing monoclonal antibodies to rat interleukin-2. Transplant Proc 1989; 21: 994.
26. Hancock WW, Sayegh MH, Sablinski T, Kut JP, Kupiec-Weglinski JW, Milford EL. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy. Transplantation 1992; 53: 1276.
27. Tanaka K, Tilney NL, Stunkel KG, Hancock WW, Diamantstein T, Kupiec-Weglinski JW. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the antiidiotype response in rat recipients of cardiac allografts. Proc Natl Acad Sci USA 1990; 87: 7375.
28. DiStefano R, Kupiec-Weglinski JW, Uhteg LC, et al. Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART18. Transplant Proc 1988; 20 (suppl 2): 217.
29. Deusch K, Lüling F, Reich K, Classen M, Wagner H, Pfeffer K. A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol 1991; 21: 1053.
30. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176: 1355.
31. Pankewycz OG, Hassarjian R, Chang C, Strom TB, Kelley VE. Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activity. J Autoimmun 1988; 1: 119.
32. Heidecke CD, Hancock WW, Jakobs F, et al. TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and longterm allograft survival. Transplant Proc 1993; 25: 540.
33. Heidecke CD, Schilling T, Jakobs F, et al. In vivo function of graft infiltrating lymphocytes during acute cellular and accelerated rejection. Z Herz, Thorax, Gefäβchir 1992; 6: 178.
34. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldman H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984; 312: 548.
35. Reinherz EL, Meuer S, Fitzgerald KA, Hussey RE, Levine H, Schlossman SF. Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell 1982; 30: 735.
36. Biddison WE, Shaw S. CD4 expression and function in HLA class II-specific T cells. Immunol Rev 1989; 109: 5.
37. Alters SE, Shizuru JA, Ackerman J, Grossman D, Seydel KB, Fathman CG. Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med 1991; 173: 491.
38. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
39. Papp I, Wieder KJ, Sablinski T, et al. Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J Immunol 1992; 148: 1308.
40. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft TH2 cell activation. Transplantation 1993; 55: 1112.
41. Luqman M, Bottomly K. Activation requirements fur CD4+ T cells differing in CD45R expression. J Immunol 1992; 149: 2300.
42. Pfeiffer C, Murray J, Madri J, Bottomly K. Selective activation of Thl-and Th2-like cells in vivo-response to human collagen IV. Immunol Rev 1991; 123: 65.
43. Mosmann TR, Moore KW. The role of IL-10 in crossre gulation of TH1 and TH2 responses. Immunol Today 1991; 12: 49.
44. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR. IL-4 in hibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J Immunol 1990; 144: 2211.
45. Peleman R, Wu J, Fargeas C, Delespesse G. Recombinant inter leukin 4 suppresses the production of interferon gamma by human mononuclear cells. J Exp Med 1989; 170: 1751.
46. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989; 142: 3857.
47. Gibbons R, Martinez O, Matli M, Heinzel F, Bernstein M, Warren R. Recombinant IL-4 inhibits IL-6 synthesis by adherent peripheral blood cells in vitro. Lymphokine Res 1990; 9: 283.
48. Standiford TJ, Strieter RM, Chensue SW, Westwick J. Kasahara K, Kunkel SL. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol 1990; 145: 1435.
49. Renkonen R, Mattila P, Majuri ML, Paavonen T, Silvennoinen O. IL-4 decreases IFN-gamma-induced endothelial ICAM-1 expression by a transcriptional mechanism. Scand J Immunol 1992; 35: 525.